Review of Current First-Line Pharmacotherapy Strategies for Thyroid Eye Disease

Review of Current First-Line Pharmacotherapy Strategies for Thyroid Eye Disease

Thyroid eye disease (TED) is a challenging autoimmune disorder that often requires therapeutic intervention. Glucocorticoids (GCs), particularly in intravenous (IV) regimens, remain the first-line treatment due to their strong anti-inflammatory and immunosuppressive effects. This paper focuses on t...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia Ryniecka, Maciej Wojszczyk, Damian Zys, Piotr Pasek, Julia Kulbacka, Michalina Wójcikiewicz, Marta Chuncia-Ileczko, Julia Kacperczyk, Filip Arczewski, Karol Dziedzic
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2025-01-01
Series:Quality in Sport
Subjects:
Thyroid eye disease (TED)
glucocorticoids (GCs)
mild TED
moderate-to-severe TED
sight-threatening TED
intravenous glucocorticoids (IVGCs)
Online Access:https://apcz.umk.pl/QS/article/view/57699
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items